RxDoctor Payments Data

Mark Waldman, MD

Dermatology · Louisville, KYNPI 1811990096

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $21,675 of the $33,151 with a category attached, or 65.4%. AbbVie accounts for 84.1% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $26,984 and has fallen 96.2% since, to $1,020 in 2025. Among dermatology clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,151in general payments, 2019–2025

Across 469 payments — averaging $70.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$28K
  • Novartis$817
  • Johnson & Johnson$733
  • UCB, Inc.$416
  • Lilly USA, LLC$407
  • Sanofi$400
  • plus $2K from 23 others

What the payments were for

  • Speaking & faculty fees$21,67565%
  • Travel & lodging$2,9459%
  • Food & beverage$8,19625%
  • Education$3351%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,151 in reported general payments places this provider in the 90th percentile of 128 dermatology providers in Kentucky.

See all dermatology providers in Kentucky

Medicare billing

Part B allowed, 2024
$246,468
Medicare patients
870
Services billed
4,423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab44$163,595
Betamethasone Dipropionate93$3,911
Acitretin11$3,758
Fluorouracil35$2,444
Clobetasol Propionate54$2,288
Desonide30$1,589
Minoxidil83$1,307
Finasteride116$1,296
Triamcinolone Acetonide106$1,184
Doxycycline Hyclate35$850
ValacyclovirValacyclovir Hcl33$809
Metronidazole18$801
Clindamycin Phosphate15$776
Ketoconazole49$766
Dutasteride26$744

Paid to pharmacies, not to this prescriber.

Other dermatology in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →